These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6314597

  • 1. Effects of nucleotides and nucleosides on the activity of cyclic AMP phosphodiesterase from rat brain.
    Murakami M, Miura S, Itoh I, Gotoh N, Nakamichi H.
    Tohoku J Exp Med; 1983 Sep; 141(1):23-31. PubMed ID: 6314597
    [Abstract] [Full Text] [Related]

  • 2. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE, Lakey T, Houslay MD.
    Biochem Pharmacol; 1989 Nov 15; 38(22):4123-36. PubMed ID: 2480793
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C, Gauthier C, Le Bec A, Soustre H.
    Am J Physiol; 1992 Mar 15; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [Abstract] [Full Text] [Related]

  • 5. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE, Diocee BK, Martin W, Moodie SA.
    Biochem J; 1990 Feb 15; 266(1):127-32. PubMed ID: 2155604
    [Abstract] [Full Text] [Related]

  • 6. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B, Pyne NJ, Houslay MD.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4047-54. PubMed ID: 2825712
    [Abstract] [Full Text] [Related]

  • 7. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF, Shoji M, Brackett NL, Helfman DM.
    J Cyclic Nucleotide Res; 1978 Dec 01; 4(6):463-74. PubMed ID: 85641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases.
    Helfman DM, Kuo JF.
    Biochem Pharmacol; 1982 Jan 01; 31(1):43-7. PubMed ID: 6277336
    [Abstract] [Full Text] [Related]

  • 12. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
    Frossard N, Landry Y, Pauli G, Ruckstuhl M.
    Br J Pharmacol; 1981 Aug 01; 73(4):933-8. PubMed ID: 6168323
    [Abstract] [Full Text] [Related]

  • 13. Separation and characterization of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum.
    Mukai J, Asai T, Naka M, Tanaka T.
    Br J Pharmacol; 1994 Feb 01; 111(2):389-90. PubMed ID: 8004382
    [Abstract] [Full Text] [Related]

  • 14. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
    King LE, Solomon SS, Hasimoto K.
    J Invest Dermatol; 1975 Jun 01; 64(6):390-6. PubMed ID: 237964
    [Abstract] [Full Text] [Related]

  • 15. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
    Shakur Y, Pryde JG, Houslay MD.
    Biochem J; 1993 Jun 15; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
    [Abstract] [Full Text] [Related]

  • 16. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
    Hidaka H, Yamaki T, Ochiai Y, Asano T, Yamabe H.
    Biochim Biophys Acta; 1977 Oct 13; 484(2):398-407. PubMed ID: 199262
    [Abstract] [Full Text] [Related]

  • 17. Stimulatory effect of vanadate on 3',5'-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads.
    Ueki H, Okuhama R, Sera M, Inoue T, Tominaga N, Morita T.
    Endocrinology; 1992 Jul 13; 131(1):441-6. PubMed ID: 1319324
    [Abstract] [Full Text] [Related]

  • 18. Cyclic nucleotide phosphodiesterase activity in bovine brain coated vesicles.
    Silva WI, Schook W, Mittag TW, Puszkin S.
    J Neurochem; 1986 Apr 13; 46(4):1263-71. PubMed ID: 2869110
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by purine compounds of cyclic GMP-stimulated cyclic AMP phosphodiesterase activity from a particulate fraction of rat striatum.
    Oleshansky MA.
    Life Sci; 1980 Sep 22; 27(12):1089-95. PubMed ID: 6158640
    [No Abstract] [Full Text] [Related]

  • 20. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ, Liu H, Palmer D, Maurice DH.
    Br J Pharmacol; 1997 Sep 22; 122(2):233-40. PubMed ID: 9313930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.